Archives of Critical Care Medicine

Published by: Kowsar

Evaluation of Vancomycin Administration After Pharmacist Intervention in the Intensive Care Unit of an Educational Hospital

Mahsa Mohammadi 1 , Azadeh Eshraghi 2 , Mohammadreza Hajiesmaeili 3 and Zahra Sahraei 4 , *
Authors Information
1 Student Research Committee, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
2 Department of Clinical Pharmacy, Faculty of Pharmacy-International Campus, Iran University of Medical Sciences, Tehran, IR Iran
3 Clinical Research Development Center, Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
4 Department of Clinical Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
Article information
  • Archives of Critical Care Medicine: August 2016, 2 (2); e9037
  • Published Online: January 31, 2016
  • Article Type: Research Article
  • Received: December 14, 2015
  • Accepted: January 16, 2016
  • DOI: 10.5812/accm.9037

To Cite: Mohammadi M, Eshraghi A, Hajiesmaeili M, Sahraei Z. Evaluation of Vancomycin Administration After Pharmacist Intervention in the Intensive Care Unit of an Educational Hospital, Arch Crit Care Med. 2016 ;2(2):e9037. doi: 10.5812/accm.9037.

Abstract
Copyright © 2016, Archives of Critical Care Medicine. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited
1. Background
2. Methods
3. Results
4. Discussion
References
  • 1. Textbookofbacteriology. TODAR's online textbook of bacteriology. Antimicrobial Agents in the Treatment of Infectious Disease. 2016. Available from: http://textbookofbacteriology.net/antimicrobial_3.html.
  • 2. Uttley AH, Collins CH, Naidoo J, George RC. Vancomycin-resistant enterococci. Lancet. 1988;1(8575-6):57-8. [PubMed: 2891921].
  • 3. Schwalbe RS, Stapleton JT, Gilligan PH. Emergence of vancomycin resistance in coagulase-negative staphylococci. N Engl J Med. 1987;316(15):927-31. doi: 10.1056/NEJM198704093161507. [PubMed: 3821839].
  • 4. Stolar MH. Drug use review: operational definitions. Am J Hosp Pharm. 1978;35(1):76-8. [PubMed: 623123].
  • 5. Ventola CL. The antibiotic resistance crisis: part 1: causes and threats. P T. 2015;40(4):277-83. [PubMed: 25859123].
  • 6. Allen NE, Nicas TI. Mechanism of action of oritavancin and related glycopeptide antibiotics. FEMS Microbiol Rev. 2003;26(5):511-32. [PubMed: 12586393].
  • 7. Salehifar E, Babamahmoodi F, Alikhani A, Ganji R, Fazli M. Drug utilization evaluation of vancomycin in a referral infectious center in mazandaran province. J Pharm Care. 2015;2(2):55-9.
  • 8. Klevens RM, Edwards JR, Tenover FC, McDonald LC, Horan T, Gaynes R, et al. Changes in the epidemiology of methicillin-resistant Staphylococcus aureus in intensive care units in US hospitals, 1992-2003. Clin Infect Dis. 2006;42(3):389-91. doi: 10.1086/499367. [PubMed: 16392087].
  • 9. von Gunten V, Reymond JP, Boubaker K, Gerstel E, Eckert P, Luthi JC, et al. Antibiotic use: is appropriateness expensive? J Hosp Infect. 2009;71(2):108-11. doi: 10.1016/j.jhin.2008.10.026. [PubMed: 19062133].
  • 10. Fahimi F, Soleymani F, Tavakoli-Ardakani M. Vancomycin Utilization Evaluation in a teaching hospital: A case-series study in Iran. J Pharm Care. 2015;1(2):51-4.
  • 11. Vazin A, Japoni A, Shahbazi S, Davarpanah MA. Vancomycin utilization evaluation at hematology-oncology ward of a teaching hospital in iran. Iran J Pharm Res. 2012;11(1):163-70. [PubMed: 24250438].
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments